資源描述:
《上海CMC培訓(xùn) Ensuring Drug Quality for Public Health The Implementation》由會員上傳分享,免費在線閱讀,更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫。
1、1EnsuringDrugQualityforPublicHealthTheImplementationBrendaUratani,Ph.D.AssistantCountryDirectorFDAChinaOffice,Beijing2OverviewChallengestoGlobalizationofDrugManufacturingFDA’sWorkinChinaGMPPrinciples:Issuesofthemostconcern3ChallengesSignificantdemandin
2、resourcesforinspectionsConsequencesofglobalization,includingmoreforeignmanufacturingandclinicaltrialssitesGreatercomplexityassociatedwithmanufacturingFDAconcernaboutthestateofindustrycomplianceandinsufficientinvestmentinmanufacturingandqualitysystems4F
3、DAInternationalEffortsFDAOverseasEffortsLong-TermGoalProductscomingtotheU.S.meetU.S.requirements.StrengthenedRegulatoryCounterpartsIndustryResponsibility:SupplyChainManagementatPointofManufacture,PointofExport,andWhenPresentedforImportation5FDAOversea
4、sPresenceCurrentLocationsChinaIndiaLatinAmericaEuropeMiddleEast(2010)6FDA’sWorkinChina78FDAChinaOfficeIn-CountryStaffBeijingChrisHickey,OfficeDirectorMikeKravchuk,Deputy(device)BrendaUratani(drug)IreneChan(food)ShanghaiCharlesAhn(druginspection)BJMarc
5、iante(deviceinspection)GuangzhouDennisDoupnik(foodinspection)DennisHudson(foodinspection)FDA/SFDAAgreement:KeyProvisionsKeyProvisions:RegistrationofdesignateddrugsanddevicesJointTraining/CapacityBuildingGreater/MoreRapidInformationSharingGreaterAccesst
6、oFacilitiesProductIntegrity/Anti-counterfeitingStrengthenedFDA,SFDACollaborationUnderMultilateralAuspices9DrugsinChina:WhatHasFDADone?FDA-SFDACollaborationInspectionsEngagementofIndustryCapacity-Building10WhatIsChinaDoing?UpdatingStandards,MethodsRevis
7、ionofChinaCGMPWorkingtoImproveDrugAdverseEventReportingTrainingEliteGroupofInspectorsRe:InternationalStandardsAttemptingtoStrengthenDrugApplicationReviewProcessTakingMoreActiveRoleinInternationalStandard-SettingShiftingFocustoConductMorePre-ApprovalIns
8、pectionsUtilizingToolstoDetectCounterfeitingSupplyChain:DevelopingToolsandStandardsforTracking/Tracing11China’sRoleinDrugDevelopment:ChallengesforChinaNeedforRegulatoryReformUniformityofimplementationofCGMPacrossallprovincesRegulatoryAu